Human gene therapy attempts to alter expression or manipulate expression of therapeutic genes or altered biological properties of living cells
Gene therapy is a modified human genetic technology to cure treatment and disease. Gene therapy may work through several mechanisms.
We are engaged in gene therapy products for the treatment of diseases such as cancer, hereditary diseases and infectious diseases including us
Plasmid DNA: Genetic engineering can be a circular DNA molecule with therapeutic genes in human cells
Some gene therapy products from viruses to transfer the genetic material of the virus, natural ability to cells, viral vectors. If modified to eliminate the ability to produce viral infections, these modified viral vectors can be used (vectors), possess therapeutic genes for human cells
Bacterial vectors: Bacteria can be used as carriers (vectors) that have been modified to prevent the infections they cause and then have therapeutic genes carried on human tissues
Human gene editing technology: The goal of genetic editing is to destroy or repair harmful gene mutations
Patient-derived cellular gene therapy products: cells removed from the patient, genetically modified (usually viral vectors), then returned to the patient
Gene therapy products are regulated by the Center for FDA Biological Product Assessment Research (CBER) biologics. Human clinical studies began submitting investigational drug (IND) applications prior to clinical research needed in the United States. Submit biologic license application (BLA), approved marketing gene therapy products
Human gene therapy product management 1 long-term follow-up, industry, draft guidance in July 2018
What is gene therapy? By adding gene replacement in the human body, gene therapy can allow physicians to treat or prevent diseases by genes. This is a test of people over 90 years back to the beginning, unfortunately, when many problems are not solved. But now, we have to prove that gene therapy is closer than ever, it is the treatment of many people's dreams. As with most other hereditary diseases, ADA-SCID is rare and in 2016 it uses gene therapy to cure 18 children, Italian scientists said that this is an ADA-SCID and This treatment is a rare disease called and this treatment has been approved for the European market and only 15 patients were diagnosed throughout Europe but the rapid growth of these technologies and the treatment of patients are Even with a small number of targets, the cost drops to the extent that most patients can afford
2017 gene therapy is gathering scientists and non scientists all over the world, and for good reasons: in another medicine or surgery, gene therapy, patient DNA, we become ourselves, this Change the genetic code - and sometimes bear responsibility for treatment known for disease. Before the interview of Genetics George Church of our recent name, he can program them as scientists say, "Gene therapy is one of the most accurate and safe mechanisms we have I guess it was
Abnormal gene - gene therapy is based on the premise to correct the root cause of the disease. Basically there are two forms of gene therapy, one of which is called somatic cell gene therapy. Patient is a representation of somatic gene therapy, of genes involved in the manipulation of cells that modification will not pass to the next generation. This is currently under investigation on the type of gene therapy for research institutes of human gene therapy and other laboratories all over the world. Another form of gene therapy called germline gene therapy involving genetically modified germ cells, changes are communicated to the next generation. For technical and ethical reasons (if any), research is currently rarely undertaken in germline intervention